| Journal Profile | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journal Title | Molecular Autism | ||||||||||||||||||||||||||||
| Journal Title Abbreviations | MOL AUTISM | ||||||||||||||||||||||||||||
| ISSN | 2040-2392 | ||||||||||||||||||||||||||||
| h-index | 44 | ||||||||||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||||||||||
| Self-Citation Ratio (2020-2021) | 4.10% | ||||||||||||||||||||||||||||
| 期刊简介 | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. | ||||||||||||||||||||||||||||
| Official Website | https://www.springer.com/journal/13229 | ||||||||||||||||||||||||||||
| Online Manuscript Submission | https://www.editorialmanager.com/MOLA | ||||||||||||||||||||||||||||
| Open Access | Yes | ||||||||||||||||||||||||||||
| Publisher | CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW | ||||||||||||||||||||||||||||
| Subject Area | GENETICS & HEREDITY | ||||||||||||||||||||||||||||
| Country/Area of Publication | ENGLAND | ||||||||||||||||||||||||||||
| Publication Frequency | |||||||||||||||||||||||||||||
| Year Publication Started | 2010 | ||||||||||||||||||||||||||||
| Annual Article Volume | 45 | ||||||||||||||||||||||||||||
| Gold OA文章占比 | |||||||||||||||||||||||||||||
| OA期刊相关信息 | |||||||||||||||||||||||||||||
| WOS期刊SCI分区 | |||||||||||||||||||||||||||||
| Indexing (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||
| Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2040-2392%5BISSN%5D | ||||||||||||||||||||||||||||
| Average Duration of Peer Review * | Authorized Data from Publisher: Data from Authors: 17 Weeks | ||||||||||||||||||||||||||||
| Competitiveness * | Data from Authors: | ||||||||||||||||||||||||||||
| Useful Links |
| ||||||||||||||||||||||||||||
| *All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. | |||||||||||||||||||||||||||||
| |
| First Previous 1 Next Last (To Page | |
| Reviews on Molecular Autism: | Write a review |
| Author: 维尔娜菲茨杰拉德 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-30 20:49:14 Please translate the following paragraph into English and Japanese  (0) Thank | 维尔娜菲茨杰拉德  |
| Author: 维尔娜菲茨杰拉德 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-30 18:19:45 The discussion section is the core part of an SCI paper because it can demonstrate the breadth and depth of the author's research. Therefore, there is no specific word limit for this section. The length of the discussion section varies depending on the article and the author, ranging from a few thousand words to tens of thousands of words (0) Thank | 维尔娜菲茨杰拉德 |
| Author: 平原文波 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-27 13:15:09 Can experiments that have not been done but are desired to be done be included in the discussion? (0) Thank | 平原文波 |
| Author: 上清雨真 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-27 10:53:35 How many words are usually recommended for a discussion? (0) Thank | 上清雨真 |
| First Previous 1 Next Last (To Page | |